Salem Investment Counselors’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.69M | Sell |
9,605
-272
| -3% | -$71.5K | 0.07% | 152 |
|
|
2026
Q1 | $2.64M | Sell |
9,877
-100
| -1% | -$27.1K | 0.08% | 140 |
|
|
2025
Q4 | $2.5M | Buy |
9,977
+684
| +7% | +$182K | 0.07% | 140 |
|
|
2025
Q3 | $2.67M | Buy |
9,293
+50
| +0.5% | +$13.4K | 0.08% | 135 |
|
|
2025
Q2 | $2.43M | Sell |
9,243
-11
| -0.1% | -$2.68K | 0.08% | 140 |
|
|
2025
Q1 | $2.15M | Buy |
9,254
+11
| +0.1% | +$2.67K | 0.08% | 138 |
|
|
2024
Q4 | $2.12M | Hold |
9,243
| – | – | 0.07% | 145 |
|
|
2024
Q3 | $2.07M | Hold |
9,243
| – | – | 0.06% | 151 |
|
|
2024
Q2 | $1.88M | Hold |
9,243
| – | – | 0.06% | 151 |
|
|
2024
Q1 | $2.02M | Hold |
9,243
| – | – | 0.07% | 143 |
|
|
2023
Q4 | $2.1M | Buy |
9,243
+6,186
| +202% | +$1.3M | 0.07% | 130 |
|
|
2023
Q3 | $615K | Sell |
3,057
-106
| -3% | -$22.4K | 0.02% | 215 |
|
|
2023
Q2 | $656K | Buy |
3,163
+250
| +9% | +$48.5K | 0.02% | 209 |
|
|
2023
Q1 | $574K | Hold |
2,913
| – | – | 0.02% | 229 |
|
|
2022
Q4 | $589K | Hold |
2,913
| – | – | 0.03% | 230 |
|
|
2022
Q3 | $513K | Hold |
2,913
| – | – | 0.02% | 229 |
|
|
2022
Q2 | $587K | Buy |
2,913
+118
| +4% | +$25.2K | 0.03% | 227 |
|
|
2022
Q1 | $633K | Sell |
2,795
-192
| -6% | -$45.2K | 0.02% | 231 |
|
|
2021
Q4 | $806K | Buy |
2,987
+74
| +3% | +$18.3K | 0.03% | 216 |
|
|
2021
Q3 | $704K | Buy |
2,913
+185
| +7% | +$46.6K | 0.04% | 204 |
|
|
2021
Q2 | $647K | Sell |
2,728
-162
| -6% | -$36.9K | 0.04% | 211 |
|
|
2021
Q1 | $633K | Buy |
2,890
+259
| +10% | +$52K | 0.04% | 191 |
|
|
2020
Q4 | $460K | Hold |
2,631
| – | – | 0.03% | 201 |
|
|
2020
Q3 | $425K | Hold |
2,631
| – | – | 0.03% | 191 |
|
|
2020
Q2 | $375K | Hold |
2,631
| – | – | 0.03% | 196 |
|
|
2020
Q1 | $286K | Hold |
2,631
| – | – | 0.03% | 202 |
|
|
2019
Q4 | $382K | Buy |
2,631
+652
| +33% | +$94.1K | 0.03% | 206 |
|
|
2019
Q3 | $286K | Hold |
1,979
| – | – | 0.03% | 218 |
|
|
2019
Q2 | $294K | Sell |
1,979
-9,079
| -82% | -$1.27M | 0.03% | 227 |
|
|
2019
Q1 | $1.65M | Buy |
11,058
+815
| +8% | +$100K | 0.17% | 101 |
|
|
2018
Q4 | $1.11M | Sell |
10,243
-815
| -7% | -$109K | 0.14% | 104 |
|
|
2018
Q3 | $1.65M | Buy |
11,058
+815
| +8% | +$124K | 0.17% | 101 |
|
|
2018
Q2 | $1.58M | Hold |
10,243
| – | – | 0.14% | 101 |
|
|
2018
Q1 | $1.42M | Hold |
10,243
| – | – | 0.16% | 101 |
|
|
2017
Q4 | $1.4M | Hold |
10,243
| – | – | 0.15% | 106 |
|
|
2017
Q3 | $1.33M | Sell |
10,243
-14
| -0.1% | -$1.87K | 0.16% | 105 |
|
|
2017
Q2 | $1.36M | Buy |
10,257
+14
| +0.1% | +$1.71K | 0.16% | 105 |
|
|
2017
Q1 | $1.27M | Hold |
10,243
| – | – | 0.14% | 124 |
|
|
2016
Q4 | $1.13M | Hold |
10,243
| – | – | 0.13% | 122 |
|
|
2016
Q3 | $12.1K | Hold |
10,243
| – | – | 0.16% | 111 |
|
|
2016
Q2 | $1.15M | Hold |
10,243
| – | – | 0.14% | 126 |
|
|
2016
Q1 | $1.03M | Hold |
10,243
| – | – | 0.13% | 132 |
|
|
2015
Q4 | $1.09M | Hold |
10,243
| – | – | 0.14% | 124 |
|
|
2015
Q3 | $946K | Hold |
10,243
| – | – | 0.12% | 136 |
|
|
2015
Q2 | $1.07M | Buy |
10,243
+931
| +10% | +$96.9K | 0.13% | 133 |
|
|
2015
Q1 | $1.01M | Buy |
9,312
+116
| +1% | +$11.9K | 0.12% | 142 |
|
|
2014
Q4 | $852K | Hold |
9,196
| – | – | 0.1% | 150 |
|
|
2014
Q3 | $804K | Hold |
9,196
| – | – | 0.1% | 157 |
|
|
2014
Q2 | $809K | Hold |
9,196
| – | – | 0.1% | 154 |
|
|
2014
Q1 | $776K | Buy |
+9,196
| New | +$733K | 0.1% | 159 |
|
Other funds holding LH
RRAM
JIC
BCWM
AAM
DIA
SFA
DDPIC
WCM
HPCM
MCM
Salem Investment Counselors's LH Position: Q2 2026 in Review
Salem Investment Counselors reduced its Labcorp (LH) stake by 2.8% in Q2 2026, selling an estimated $71.5K and leaving 9,605 shares worth $2.69M. The position accounts for 0.07% of the portfolio, ranked #152.
Salem Investment Counselors first reported a position in LH in Q1 2014 and has held it in 50 quarters since. 329 funds tracked by Wall St. Rank hold LH as of Q2 2026.
- Salem Investment Counselors held 9,605 shares of Labcorp worth $2.69M as of Q2 2026.
- Salem Investment Counselors sold 272 Labcorp shares in Q2 2026, an estimated $71.5K.
- Labcorp made up 0.07% of Salem Investment Counselors's portfolio in Q2 2026, its #152 holding.
- Salem Investment Counselors first reported a position in Labcorp in Q1 2014 and has held it in 50 quarters since.
- 329 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.
Based on Salem Investment Counselors's 13F filing for Q2 2026, filed 14 Jul 2026.